Biogen, Inc. (BIIB)
218.12
+1.34
(+0.62%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
-0.01
(-0.00%)
After-Hours: 20:00
Biogen Debt to Equity Ratio : 0.4433 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4433 |
| March 31, 2026 | 0.3518 |
| December 31, 2025 | 0.3647 |
| September 30, 2025 | 0.3619 |
| June 30, 2025 | 0.374 |
| March 31, 2025 | 0.39 |
| December 31, 2024 | 0.4018 |
| September 30, 2024 | 0.4066 |
| June 30, 2024 | 0.4191 |
| March 31, 2024 | 0.4566 |
| December 31, 2023 | 0.5019 |
| September 30, 2023 | 0.5327 |
| June 30, 2023 | 0.4555 |
| March 31, 2023 | 0.4791 |
| December 31, 2022 | 0.5009 |
| September 30, 2022 | 0.5193 |
| June 30, 2022 | 0.636 |
| March 31, 2022 | 0.6749 |
| December 31, 2021 | 0.706 |
| September 30, 2021 | 0.7305 |
| June 30, 2021 | 0.7099 |
| March 31, 2021 | 0.7159 |
| December 31, 2020 | 0.7394 |
| September 30, 2020 | 0.7282 |
| June 30, 2020 | 0.6931 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5073 |
| December 31, 2019 | 0.4827 |
| September 30, 2019 | 0.4597 |
| June 30, 2019 | 0.4975 |
| March 31, 2019 | 0.4665 |
| December 31, 2018 | 0.4553 |
| September 30, 2018 | 0.4308 |
| June 30, 2018 | 0.4835 |
| March 31, 2018 | 0.4221 |
| December 31, 2017 | 0.4708 |
| September 30, 2017 | 0.5063 |
| June 30, 2017 | 0.5623 |
| March 31, 2017 | 0.5675 |
| December 31, 2016 | 0.5368 |
| September 30, 2016 | 0.5393 |
| June 30, 2016 | 0.5738 |
| March 31, 2016 | 0.6334 |
| December 31, 2015 | 0.6963 |
| September 30, 2015 | 0.618 |
| June 30, 2015 | 0.0461 |
| March 31, 2015 | 0.0501 |
| December 31, 2014 | 0.0541 |
| September 30, 2014 | 0.0563 |
| June 30, 2014 | 0.0617 |
| March 31, 2014 | 0.0651 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ionis Pharmaceuticals, Inc. | 4.978 |
| AbbVie, Inc. | -11.93 |
| Gilead Sciences, Inc. | 2.219 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| Amgen, Inc. | 4.903 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 32.09B |
| Total Liabilities (Quarterly) | 13.24B |
| Shareholders Equity (Quarterly) | 18.85B |
| Current Ratio | 1.865 |
| Net Debt Paydown Yield | -1.09% |